Cannabix Technologies Adds Dr. Randall Purves as Scientific Advisor
May 13, 2019
Vancouver, British Columbia, May 13, 2019 -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company”) is pleased to announce that Dr. Randy Purves has been appointed as a Scientific Advisor to Cannabix Technologies Inc. Dr. Purves is one of the world’s foremost experts in the development of FAIMS (high-field asymmetric waveform ion mobility spectrometry) instrumentation and applications. Dr. Purves is a pioneer in developing FAIMS technology and in 2001 he co-founded Ionalytics, an instrument company specializing in FAIMS devices for use with mass spectrometry. Ionalytics was acquired by Thermo Electron (now Thermo Fisher Scientific) in 2005 and Dr. Purves was part of the Thermo team involved with the commercial release of an integrated FAIMS product for use with a TSQ Quantum mass spectrometer in 2006.
Dr. Randy Purves obtained his Ph.D. in Analytical Chemistry from the University of Alberta. Dr. Purves has over 25 years of experience working with mass spectrometry, which includes working in drug metabolism at Merck Frosst. Dr. Purves is an expert in the development and application of FAIMS, having co-authored 45 refereed publications in FAIMS and differential mobility spectrometry (DMS) in general. Dr. Purves is an adjunct professor in the College of Pharmacy and Nutrition at the University of Saskatchewan and continues to collaborate with Thermo Fisher Scientific on further enhancing FAIMS technology for mass spectrometry based applications. A primary interest of Dr. Purves is to use his expertise in FAIMS and small molecule analysis to improve quantification methods of analytes in challenging matrices.
Dr. Raj Attariwala, Cannabix’s Chief Scientific Officer, states, “Dr. Purves has deep, unparalleled experience with FAIMS technology that will be a tremendous benefit to our scientific team and technology development.”
The Company has granted Dr. Purves 150,000 stock options exercisable at $1.50 for a period of 2 years.
The information in these press releases is historical in nature, has not been updated, and is current only to the date indicated in the particular press release. This information may no longer be accurate and therefore you should not rely on the information contained in these press releases. To the extent permitted by law, Cannabix Technologies Inc. and its employees, agents and consultants exclude all liability for any loss or damage arising from the use of, or reliance on, any such information, whether or not caused by any negligent act or omission.